AFJK
NASDAQ · N/A
Aimei Health Technology Co
$48.46
+0.62 (+1.30%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 110.00M | 109.02M | 101.11M |
| Net Income | 15.93M | 13.20M | 11.48M |
| EPS | — | — | — |
| Profit Margin | 14.5% | 12.1% | 11.4% |
| Rev Growth | +22.9% | +24.7% | -9.9% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 45.59M | 36.51M | 48.28M |
| Total Equity | 141.71M | 141.78M | 158.87M |
| D/E Ratio | 0.32 | 0.26 | 0.30 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 19.91M | 20.67M | 18.51M |
| Free Cash Flow | 14.64M | 13.56M | 9.61M |